Novel covalent CDK7 inhibitor potently induces apoptosis in acute myeloid leukemia and synergizes with Venetoclax
2023 · Journal of Experimental & Clinical Cancer Research · 25 citations
https://doi.org/10.1186/s13046-023-02750-w
M
Murali Ramchandra
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
7
Papers
54
Citations
2
h-index
2
i10-index
Murali Ramchandra is an academic researcher from Aurigene Discovery Technologies (India). The author has contributed to research in topics: Cancer-related Molecular Pathways & Acute Myeloid Leukemia Research & Cancer therapeutics and mechanisms. The author has an h-index of 2, co-authored 6 publications.
Papers by this author
worksAdditional file 1 of Novel covalent CDK7 inhibitor potently induces apoptosis in acute myeloid leukemia and synergizes with Venetoclax
2023 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.23803051
Additional file 2 of Novel covalent CDK7 inhibitor potently induces apoptosis in acute myeloid leukemia and synergizes with Venetoclax
2023 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.23803054
Additional file 3 of Novel covalent CDK7 inhibitor potently induces apoptosis in acute myeloid leukemia and synergizes with Venetoclax
2023 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.23803057
A Covalent CDK7 Inhibitor Overcomes Venetoclax Resistance and Induces Apoptosis via C-Myc/p53 Axis in Acute Myeloid Leukemia
2024 · Clinical Lymphoma Myeloma & Leukemia · 0 citations
https://doi.org/10.1016/s2152-2650(24)00508-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat